NASDAQ:IMCR
Immunocore Holdings plc Stock News
$46.05
-1.93 (-4.02%)
At Close: May 24, 2024
Immunocore Holdings: Unlocking The Immune System's Hidden Potential
03:49am, Sunday, 11'th Jun 2023
Immunocore Holdings is a leading biotech firm with a promising pipeline of T cell receptor-based bispecific immunotherapies for cancer, autoimmune diseases, and infectious illnesses. Immunocore's fina
Immunocore to present at upcoming investor conferences
04:30pm, Thursday, 01'st Jun 2023
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md.
Immunocore to present at the Bank of America Securities 2023 Health Care Conference
04:30pm, Wednesday, 03'rd May 2023
Immunocore to present at the Bank of America Securities 2023 Health C are Conference
Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
07:00am, Tuesday, 11'th Apr 2023
Immunocore to present at the 22 nd Annual Needham Virtual Healthcare Conference
Immunocore Holdings PLC Sponsored ADR (IMCR) is Attracting Investor Attention: Here is What You Should Know
10:41am, Thursday, 30'th Mar 2023
Zacks.com users have recently been watching Immunocore Holdings PLC Sponsored ADR (IMCR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Immunocore Holdings PLC Sponsored ADR (IMCR) Is a Trending Stock: Facts to Know Before Betting on It
10:43am, Thursday, 16'th Mar 2023
Recently, Zacks.com users have been paying close attention to Immunocore Holdings PLC Sponsored ADR (IMCR). This makes it worthwhile to examine what the stock has in store.
Immunocore to present four posters at AACR Annual Meeting 2023
04:30pm, Tuesday, 14'th Mar 2023
Immunocore to present four posters at AACR Annual Meeting 2023
Immunocore Holdings plc (IMCR) Q4 2022 Earnings Call Transcript
01:33pm, Wednesday, 01'st Mar 2023
Immunocore Holdings plc (NASDAQ:IMCR ) Q4 2022 Earnings Conference Call March 1, 2023 8:00 AM ET Company Participants Clayton Robertson - Head of Investor Relations Bahija Jallal - Chief Executive Off
Is a Surprise Coming for Immunocore (IMCR) This Earnings Season?
09:48am, Tuesday, 28'th Feb 2023
Immunocore (IMCR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Immunocore to present at upcoming investor conferences
07:00am, Tuesday, 28'th Feb 2023
Immunocore to present at upcoming investor conferences
Immunocore Holdings: A Meteoric Rise Likely Here To Stay
03:51am, Monday, 27'th Feb 2023
Immunocore Holdings has strong, incremental sales and financials, a positive outlook. Total market dominance ensures demand for its products.
Investors Heavily Search Immunocore Holdings PLC Sponsored ADR (IMCR): Here is What You Need to Know
10:32am, Friday, 24'th Feb 2023
Immunocore Holdings PLC Sponsored ADR (IMCR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Immunocore Holdings PLC Sponsored ADR (IMCR) Surges 6.5%: Is This an Indication of Further Gains?
06:47am, Tuesday, 14'th Feb 2023
Immunocore Holdings PLC Sponsored ADR (IMCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving hi
Biotech's Drug Pipeline Expands From Melanoma To Other Cancers
01:50pm, Monday, 13'th Feb 2023
Immunocore is the IBD Stock of the Day as the biotech company expands its pipeline. Earnings For IMCR stock are due in March.
Is Biotech Immunocore About To Make A 25% Price Move?
07:00am, Tuesday, 07'th Feb 2023
The industry is home to some large-cap heavyweights, including Amgen Inc. (NASDAQ: AMGN), Gilead Sciences Inc. (NASDAQ: GILD), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Vertex Pharmaceuticals Inc
